Phase 2 Study of Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma: Updated Safety Analysis on Prevalence of Infection, Diarrhea, and Bleeding over TimeS. Rule,M. L. Wang,P. Martin,R. Auer,B. S. Kahl,W. Jurczak,R. H. Advani,J. Romaguera, M. Williams,J. C. Barrientos,E. Chmielowska,J. A. Radford,S. Stilgenbauer, V. Truong,M. Chang,D. M. Beaupre,A. Goy,K. A. BlumHAEMATOLOGICA（2014）引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
